LANXESS AG Business Summary

LANXESS AG (LNXSY) is a leading global specialty chemicals company that operates through a pure-play business model focused on the development, manufacturing, and marketing of high-margin chemical intermediates, additives, and consumer protection products. The company generates revenue through direct product sales across three primary segments: Advanced Intermediates, which provides high-quality industrial precursors; Specialty Additives, encompassing plastic, lubricant, and colorant additives; and Consumer Protection, which focuses on material protection, flavors, and fragrances. Strategically, LANXESS has transitioned toward an asset-light structure, evidenced by the 2025 divestment of its Urethane Systems business to UBE Corporation. It competes directly with major chemical players such as BASF, Evonik, Arkema, and Clariant, positioning itself as a specialized, high-efficiency alternative to diversified commodity chemical giants by prioritizing sustainable, customized solutions for the automotive, construction, and electronics industries. Originally spun off from Bayer AG in 2004, the company is currently led by Matthias Zachert, who has served as Chairman of the Board of Management (CEO) since 2014 and previously held the role of CFO at both LANXESS and Merck KGaA. The executive leadership team includes Oliver Stratmann as Chief Financial Officer, Dr. Hubert Fink, who oversees production and technology, and Frederique van Baarle, who serves as Labor Director and President of LANXESS Americas. The Supervisory Board is chaired by Dr. Rainier van Roessel and features notable industry veterans such as Hans van Bylen, the former CEO of Henkel. As of February 2026, the company maintains a strong institutional investor base, with recent filings indicating significant positions held by firms such as Morgan Stanley and Lowell Capital Management.